(Total Views: 185)
Posted On: 09/08/2020 3:20:47 PM
Post# of 13
$CTDH News Article - Cyclo Therapeutics Inc. Announces Additional Efficacy Data from its Ongoing Phase I/II Trial using Trappsol CycloTM Intravenously to Treat Patients with Niemann-Pick Disease Type C1 (NPC1) https://marketwirenews.com/news-releases/cycl...02757.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
